SEARCH

SEARCH BY CITATION

References

  • Airaksinen M. and Saarma M. (2002) The GDNF family: signaling, biological functions and therapeutic value. Nature Rev. Neurosci. 3, 383394.
  • Alberti L., Borrello M. G., Ghizzoni S., Torriti F., Rizzett M. G. and Pierotti M. A. (1998) Grb2 binding to the different isoforms of Ret tyrosine kinase. Oncogene 17, 10791087.
  • Bain J., Plater L., Elliott M., Shapiro N., Hastie C. J., McLauchlan H., Klevernic I., Arthur J. S. C., Alessi R. A. and Cohen P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297315.
  • Bespalov M. M. and Saarma M. (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol. Sci. 28, 6874.
  • Besset V., Scott R. P. and Ibanez C. F. (2000) Signaling complexes and protein-protein interactions are involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275, 3915939166.
  • Bjorge J. D., Jakymiw A. and Fujits D. J. (2000) Selected glimpses into the activation and function of Src kinases. Oncogene 19, 56205635.
  • Bohn M. C. (1999) A commentary on glial cell line-derived neurotrophic factor (GDNF). From A glial secreted molecule to gene therapy. Biochem. Pharmacol. 57, 135142.
  • Brown M. T. and Cooper J. A. (1996) Regulation, substrates and function of src. Biochim. Biophys. Acta 1287, 121149.
  • Caré B. R. and Soula H. A. (2011) Impact of receptor clustering on ligand binding. CMC Systems Biology 5, 48.
  • Carlomagno F., Vitagliano D., Guida T., Napolitano M., Vecchio G., Fusco A., Gazit A., Levitzki A. and Santoro M. (2002) The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. Cancer Res. 62, 10771082.
  • Carlomagno F., Vitsagliano D., Guida T., Basolo F., Castellone M. D., Melillo R. M., Fusco A. and Santoro M. (2003) Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phrnyl0-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). J. Clin. Endo. Metabol. 88, 18971902.
  • Carniti C., Perego C., Mondellini P., Picrotti M. A. and Bongarzone I. (2003) PP1 inhibitor induces degradation of RETMEN2A and RETMEN2B oncoproteins through proteosomal targeting. Cancer Res. 63, 22342243.
  • Cik M., Masure S., Lasage A. S. J., Van der Linden I., Van Gompel P., Pangalos M. N., Gordon R. D. and Leysen J. E. (2000) Binding of GDNF and neurturin to human GDNF family receptor α1 and α2. J. Biol. Chem. 275, 2750527512.
  • Coulpier M., Anders J. and Ibanez C. F. (2002) Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase. J. Biol. Chem. 277, 19911999.
  • De Vita G., Melillo R. M., Carlomagno F., Visconti R., Castellone M. D., Bellacosa A., Billaud M., Fusco A., Tsichlis P. N. and Santoro M. (2000) Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 survival. Cancer Res. 60, 37273731.
  • Duchemin A. M., Ren Q., Mo L., Neff N. H. and Hadjiconstantinou M. (2002) GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J. Neurochem. 81, 696707.
  • Duchemin A. M., Ren Q., Neff N. H. and Hadjiconstantinou M. (2008) GM1-induced activation of phosphatidylinositol 3-kinase: involvement of Trk receptors. J. Neurochem. 104, 24661477.
  • Duchemin A. M., Zhang H., Neff N. H. and Hadjiconstantinou M. (2009) Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal. Neurosci. Lett. 467, 182186.
  • Durbec P., Marcos-Gutierrez C., Kilkenny C. et al. (1996) GDNF signaling through the Ret receptor tyrosine kinase. Nature 381, 789793.
  • Eketjall S., Fainzilber M., Murray-Rust J. and Ibanez C. F. (1999) Distinct structural elements in GDNF mediate binding to GFRα1 and activation of the GFRα1-c-Ret receptor complex. EMBO J. 18, 59015910.
  • Encinas M., Tansey M., Tsui-Pierchala B., Comella J., Milbrandt J. and Johnson E. M., Jr (2001) c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand mediated neuronal survival via a phosphatidylinositol 3-kinase (PI-3K)-dependent pathway. J. Neurosci. 21, 14641472.
  • Encinas M., Crowder R., Milbrandt J. and Johnson E. M., Jr (2004) Tyrosine 981, a novel Ret autophosphorylation site, binds c-src to mediate neuronal survival. J. Biol. Chem. 279, 1826218269.
  • Esposito C. L., D'Alessio A., de Franciscis V. and Cerchia L. (2008) A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cell differentiation. PLoS ONE 3, e1643.
  • Fantini J. and Barrantes F. J. (2009) Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta 1788, 23452361.
  • Goettl V. M., Wemlinger T. A., Duchemin A. M., Neff N. H. and Hadjiconstantinou M. (1999) GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats. Neuroscience 92, 9911000.
  • Goettl V. M., Welinger T. A., Fong T. G., Neff N. H. and Hadjiconstantinou M. (2000) Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside. Brain Res. 877, 16.
  • Goettl V. M., Neff N. H. and Hadjiconstantinou M. (2002) Sciatic nerve axotomy in aged rats: response of motoneurons and the effect of GM1 ganglioside treatment. Brain Res. 968, 4453.
  • Goettl V. M., Zhang H., Burrows A. C., Wemlinger T. A., Neff N. H. and Hadjiconstantinou M. (2003) GM1 enhances dopaminergic markers in the brain of aged rats. Exp. Neurol. 183, 665672.
  • Golden J., Baloh R., Kotzbauer P., Lampe P., Osborne P., Milbrandt J. and Johnson E. M., Jr (1998) Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J. Comp. Neurol. 398, 139150.
  • Hadjiconstantinou M. and Neff N. H. (1988) Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 51, 11901196.
  • Hadjiconstantinou M. and Neff N. H. (1998) GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems. J. Neurochem. 70, 13351345.
  • Hadjiconstantinou M. and Neff N. H. (2000) GM1 ganglioside: Commonalities of action with neurotrophins, in Neurobiology of the Neurotrophins, (Mocchetti I., ed.), pp. 427453. FP Graham Publishing Co., Johnson City, TN.
  • Hadjiconstantinou M., Rosetti Z., Paxton R. and Neff N. H. (1986) Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. Neuropharmacol. 25, 10751077.
  • Hadjiconstantinou M., Mariani A. and Neff N. H. (1989) GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Brain Res. 484, 297303.
  • Hadjiconstantinou M., Newburn E. and Neff N. H. (2010) Ret phosphorylation and activation by GM1. ASN Abstracts. Neurodegenerative diseases, Ab PTW06. American Society for Neurochemistry, Santa Fe, NM.
  • Hanke J. H., Gardner J. P., Dow R. L., Changelian P. S., Brissette W. H., Weringer E. J., Pollok B. A. and Connelly P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study on Lck- and Fyn-dependent T cell activation. J. Biol. Chem. 271, 695701.
  • Hayashi H., Ichihara M., Murakami H. et al. (2000) Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19, 44694475.
  • Holtzman D. M., Kilbridge J., Li Y., Cunningham E. T., Lenn N. J., Clary D. O., Reichardt L. F. and Mobley W. C. (1995) TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons. J. Neurosci. 15, 15671578.
  • Ibanez C. F. (2013) Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb. Perspect. Biol. 5, a009134.
  • Jing S., Wen D., Yu Y. et al. (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85, 11131124.
  • Jing S., Yu Y., Fang M., Hu Z., Holst P. L., Boone T., Delaney J., Schultz H., Zhou R. and Fox G. M. (1997) GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272, 3311133317.
  • Kasahara K. and Sanai Y. (2000) Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconjugate J. 17, 153162.
  • Knowles P. P., Rust-Murray J., Kjaer S., Scott R. P., Hanrahan S., Santoro M., Ibanez C. F. and McDonald N. Q. (2006) Structure and chemical inhibition of the RET tyrosine kinase domain. J. Biol. Chem. 282, 3357733587.
  • Kordower J. H. and Bjorklund A. (2013) Trophic factor gene therapy for Parkinson's disease. Mov. Disord. 28, 96109.
  • Lamballe F., Smeyne R. J. and Barbacid M. (1994) Developmental expression of trkC, the neurotrophin-3 receptor, in the mammalian nervous system. J. Neurosci. 14, 1428.
  • Lin L., Doherty D., Lile J., Bektesh S. and Collins F. (1993) GDNF: a glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 11301132.
  • Loberto N., Prioni S., Prinetti A., Ottico E., Chigomo V., Karagogeos D. and Sonnino S. (2003) The adhesion protein TAG-1 has a ganglioside environment in the sphingolipid-enriched membrane domains of neuronal cells in culture. J. Neurochem. 85, 224233.
  • Martinez Ferrando I., Chaerkady R., Zhong J. et al. (2012) Identification of targets of cSrc tyrosine kinase by chemical complementation and phosphoproteomics. Mol. Cell. Proteomics 11, 355369.
  • Mo L., Ren Q., Duchemin A. M., Neff N. H. and Hadjiconstantinou M. (2005) GM1 and Erk signaling in the aged brain. Brain Res. 1054, 125134.
  • Mocchetti I. (2005) Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell. Mol. Life Sci. 62, 22832294.
  • Mologni L., Sala E., Riva B., Cesaro L., Cazzaniga S., Redaelli S., Marin O., Pasquato N., Donella-Deana A. and Gambacorti-Passerini C. (2005) Expression, purification, and inhibition of human RET tyrosine kinase. Protein Exp. Purif. 41, 177185.
  • Mutoh T., Tokuda A., Miyadai T., Hamaguchi M. and Fujiki N. (1995) Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl Acad. Sci. USA 92, 50875091.
  • Newburn E. N., Hadjiconstantinou M. and Neff N. H. (2005) Activation of Ret by GM1 ganglioside. Society for Neuroscience Abstracts. Program No 338.4, Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC.
  • Newburn E. N., Hadjiconstantinou M. and Neff N. H. (2007) GM1 signaling through the GDNF receptor complex. Society for Neuroscience Abstracts. Program No 254.6 Abstract viewer/Itinerary planner. Society for Neuroscience, San Diego, CA.
  • Nishio M., Fukumoto S., Furukawa K., Ichimura A., Miyazaky H., Kusunoki S., Urano T. and Furukawa K. (2004) Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J. Biol. Chem. 279, 3336833378.
  • Nosrat C. A., Tomac A., Hoffer B. and Olson L. (1997) Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp. Brain Res. 115, 410422.
  • Numan S. and Serrogy K. B. (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403, 295308.
  • Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R. and Ibanez C. F. (2001) Released GFRα1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29, 171184.
  • Pierchala B. A., Tsui C. C., Milbrandt J. and Johnson E. M. (2007) NGF augments the autophopshorylation of Ret via inhibition of ubiquitin-dependent degradation. J. Neurochem. 100, 11691176.
  • Pong K., Xu R. Y., Baron W. F., Louis J. C. and Beck K. D. (1998) Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons. J. Neurochem. 71, 19121919.
  • Posse de Chaves E. and Sipione S. (2010) Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 584, 17481759.
  • Prinetti A., Iwabuchi K. and Hakomori S. (1999) Glycosphingolipid-enriched signaling domain in mouse neuroblastoma neuro2a cells. J. Biol. Chem. 274, 2091620924.
  • Prioni S., Mauri L., Loberto N., Casellato R., Chigorno V., Karagogeos D., Prinetti A. and Sonnino S. (2004) Interactions between gangliosides and proteins in the exoplasmic leaflet of neuronal plasma membranes: a study performed with tritium-labeled GM1 derivative containing a photoactivable group linked to the oligosaccharide chain. Glycoconjugate J. 21, 461470.
  • Qiao S., Iwashita T., Furukawa T., Yamamoto M., Sobue G. and Takahashi M. (2001) Differential effects of leucocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. J. Biol. Chem. 276, 94609467.
  • Rabin S. J., Bacchis A. and Mochetti I. (2002) Gangliosides activate Trk receptors by inducing the release of neurotrophins. J. Biol. Chem. 277, 4946649472.
  • Runeberg-Roos P. and Saarma M. (2007) Neurotrophic factor receptor Ret: structure, cell biology, and inherited diseases. Ann. Med. 39, 572580.
  • Sarabi A., Hoffer B., Olson L. and Morales M. (2001) GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J. Comp. Neurol. 441, 106117.
  • Sariola H. and Saarma M. (2003) Novel functions and signaling pathways for GDNF. J. Cell. Science 116, 38553862.
  • Sawada H., Ibi M., Urushitani M., Nakahishi M., Akaike A. and Shimohama S. (2000) Neuroprotective mechanism of glia cell line-derived neurotrophic factor in mesencephalic neurons. J. Neurochem. 74, 11751184.
  • Shwarzmann G. (2001) Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Cell Devel. Biol. 12, 163171.
  • Sobreviella T., Clary D. O., Reichardt L. F., Brandabur M. M., Kordower J. H. and Mufson E. J. (1994) TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350, 587611.
  • Sonnino S., Pronetti A., Mauri L. and Tettamanti G. (2006) Dynamic and structural properties of sphingolipids as driving force to the formation of membrane domains. Chem. Rev. 106, 21112125.
  • Sullivan A. M. and Toulouse A. (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokines & Growth Factors Reviews 22, 157165.
  • Takahashi M., Asai N., Iwashita T., Isomura T., Miyazaki K. and Matsuyama M. (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene 8, 29252929.
  • Tansey M., Baloh R., Millbrandt J. and Johnson E. M., Jr (2000) GFRα1-mediated localization of Ret to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 25, 611623.
  • Treanor J. J., Goodman L., de Sauvage F. et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 8083.
  • Trupp M., Arenas E., Fainzilber M. et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785789.
  • Trupp M., Belluardo N., Funakoshi H. and Ibanez C. F. (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17, 35543567.
  • Trupp M., Scott R., Whittemore S. R. and Ibanez C. F. (1999) Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J. Biol. Chem. 274, 2088520894.
  • Tsui-Pierchala B. A., Ahrens R. C., Crowder R. J., Milbtrandt J. and Johnson E. M., Jr (2002a) The Long and short isoforms of Ret function as independent signaling complexes. J. Biol. Chem. 277, 3461834625.
  • Tsui-Pierchala B. A., Milbrandt J. and Johnson E. M., Jr (2002b) NGF utilizes c-Ret via a novel GFL-independent, inter-RTK, signaling mechanism to maintain the trophic status of mature sympathetic neurons. Neuron 33, 261273.
  • Uehara Y., Fukazawa H., Murakami Y. and Mizuno S. (1989) Irreversible inhibition of V-Src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem. Biophys. Res. Comm. 163, 803809.
  • Ugarte S. D., Lin E., Klann E., Zigmond M. J. and Perez R. G. (2003) Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J. Neurosci. Res. 73, 105112.
  • Wang X. (2013) Structural studies of GDNF family ligands with their receptors - Insights into ligand recognition and activation of receptor tyrosine kinase Ret. Biochim. Biophys. Acta 1834, 22052212.
  • Weihmuller F. B., Hadjiconstantinou M., Bruno J. P. and Neff N. H. (1988) Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice. Neurosci. Lett. 92, 207212.